Targeting Tumor Vasculature With an Oncolytic Virus

This publication has 23 references indexed in Scilit:

• Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases
  Nature Medicine, 2010
• Double trouble for tumours: Exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses
  Cytokine & Growth Factor Reviews, 2010
• Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice
  Journal of Clinical Investigation, 2010
• Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
  Nature Reviews Cancer, 2009
• The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma
  Molecular Therapy, 2008
• Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
  Nature Reviews Microbiology, 2008
• Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium
  Blood, 2004
• Getting oncolytic virus therapies off the ground
  Cancer Cell, 2003
• The Role of CC Chemokine Receptor 2 in Alveolar Monocyte and Neutrophil Immigration in Intact Mice
  American Journal of Respiratory and Critical Care Medicine, 2002
• Viral Vascular Endothelial Growth Factor Plays a Critical Role in Orf Virus Infection
  Journal of Virology, 2000